San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

Company’s Eye Drops Could Be Replacement for Reading Glasses

PHARMA: Company May Seek Partnership During Final Trials

A small and low-key drugmaker in Coronado is making an eye drop product that may replace reading glasses.

Tease photo

A Commanding Presence

BIOTECH: NuVasive’s Lucier Sets Cadence for Co.’s March Toward Its Goals

Greg Lucier ranks high on my list of San Diego bigwigs, but the biotech executive has largely eluded me for the past two years.

Abreos Biosciences Raises $725,000 in Funding

San Diego’s Abreos Biosciences has raised $725,000 in a seed round of funding.

Oncternal Therapeutics Pediatric Cancer Drug Gets Orphan Drug Designation

San Diego’s Oncternal Therapeutics Inc. has been granted an Orphan Drug Designation by the U.S. Food and Drug Administration for its pediatric cancer drug candidate.

Tease photo

Bill VanDeWeghe Named CEO of BioSurplus Inc.

BioSurplus Inc., a local company that buys and sells pre-owned lab equipment, has appointed Bill VanDeWeghe as its new president and chief executive officer.

NASA-Affiliated Group Overseeing Space Station Lab Opens Local Office

CASIS, the organization that manages the U.S. national lab on the International Space Station, is setting up a permanent office in San Diego, Mayor Keven Faulconer announced on July 12.

Trovogene Announces Another Collaboration, This One With USC

Trovagene Inc., a local firm that makes liquid biopsy tests, is collaborating with the University of Southern California’s Norris Comprehensive Cancer Center on the best way to use its tests in the clinic, the company announced Tuesday.

Presbyopia Therapies Raises Nearly $4 Million in Equity Financing

Coronado-based Presbyopia Therapies LLC has raised nearly $4 million in equity financing, according to a recent form filed with the Securities and Exchange Commission.

Sorrento Therapeutics to Partner With French Pharma Servier

Sorrento Therapeutics Inc., a local biopharmaceutical company, has landed a partnership with French pharmaceutical giant Servier to develop products based on Sorrento’s tech.

Illumina Pays Enzo Life Sciences $21 Million to Settle Patent Dispute

Illumina Inc. has settled a patent-infringement lawsuit with New York-based Enzo Biochem subsidiary Enzo Life Sciences for $21 million, according to several wire services.

Two Bond Rating Agencies Give Palomar Health Good Grades

Two major bond credit rating services have weighed in on the fiscal health of Palomar Health, the public hospital district announced.

Tease photo

TPP Safeguards Future of Life Science Industry

From the polio vaccine to the MRI scanner, America has a rich history of developing lifesaving medicines. The Trans-Pacific Partnership (TPP) trade agreement is important to small pharmaceutical companies like mine and our ability to bring the next generation of medicines to the global marketplace.

FDA Hold Takes Valuable Time From Regulus’ Lead Product

It’s tough times for Regulus Therapeutics Inc. Once a local biotech heavyweight valued at nearly $1 billion, the San Diego company’s shares have fallen dramatically over the last 18 months. The company’s valuation is hovering around $170 million after the latest blow: a FDA-ordered suspension on Regulus’ lead product candidate, RG-101.

Tease photo

Biotech Financing

BIOTECH: Halozyme Gets Creative in Pursuit of Cash

In today’s market, with valuations down and investors wary, it’s critical for biotechs to get creative when looking for cash to fuel research.

Germany-based Curetis GmbH Opens North American subsidiary in San Diego

Germany-based Curetis GmbH has opened a North American subsidiary in San Diego and named Christopher M. Bernard as its leader.